NCT06937658

Brief Summary

The Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs). The study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Feasibility Phase of the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
May 2025Jun 2026

First Submitted

Initial submission to the registry

April 8, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 22, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

January 7, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

April 8, 2025

Last Update Submit

January 5, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Enrollment

    Number of patients enrolled and randomized per site and per month, and cumulatively

    6 months

  • Adherence

    Proportion of cross-over

    6 months

Secondary Outcomes (9)

  • Major adverse cardiac events

    6 months

  • Major adverse cardiac events

    6 months

  • Effectiveness

    6 months

  • Effectiveness

    6 months

  • Connectivity

    6 months

  • +4 more secondary outcomes

Study Arms (2)

Guideline-based Care

ACTIVE COMPARATOR

Remote monitoring programming scheduled for alert transmissions, patient-initiated transmissions, and routine transmissions (scheduled to occur every 90 days from the date of enrollment in the study); in-office interrogations on at least an annual basis

Device: Guideline-based care

Alert-based Care

ACTIVE COMPARATOR

Remote monitoring programming scheduled for alert transmissions and patient-initiated transmissions only

Device: Alert-based care

Interventions

Alert-based care is an alternative strategy for longitudinal management of patients with wireless pacemakers and implantable defibrillators

Alert-based Care

Guideline-based care is the current typical standard for longitudinal management of patients with wireless pacemakers and implantable defibrillators

Guideline-based Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult aged \> 18 years
  • Clinically stable by investigator assessment
  • Has a newly implanted or existing wireless CIED: single, dual-chamber, biventricular, subcutaneous/extravascular, and leadless systems are all eligible, including pacemakers or implantable cardioverter-defibrillators (ICDs)
  • CIED is from one of the 4 major CIED manufacturers in the US market (99% of implants in the US): Medtronic, Boston Scientific, Abbott, Biotronik
  • Currently enrolled in remote monitoring as part of standard of care
  • Primary clinical electrophysiology follow-up at the enrolling center
  • Understands spoken and written English, Spanish, or Portuguese
  • Has sufficient cognitive function to answer standardized questions about study rationale and procedures.

You may not qualify if:

  • Presence of insertable cardiac monitor, either in isolation or in combination with any other CIED
  • Listed for cardiac transplantation prior to enrollment (N.B. if a patient becomes listed for transplantation during the study, they may continue study participation)
  • Participation in another study related to novel CIED technology or remote monitoring.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

RECRUITING

Central Study Contacts

Linda Valsdottir, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

April 8, 2025

First Posted

April 22, 2025

Study Start

May 1, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

January 7, 2026

Record last verified: 2026-01

Locations